CD274 and pancreatic neoplasm: Recent studies have reported that tumor-specific T cells were recruited to the tumor microenvironment and that immune checkpoint expression, including PD-L1, was upregulated in response to therapeutic vaccines in pancreatic cancer [9, 35].